e-learning
resources
Munich 2014
Sunday, 07.09.2014
Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC 2014 abstract - Deglycosylated bleomycin, while keeping bleomycin's antitumor activity, is devoid of its strong pulmonary toxicity
O. Burgy, G. Wettstein, P. S. Bellaye, D. Nathalie, A. Kenani, J. F. Hernandez, A. Bettaieb, P. Camus, C. Garrido, P. Bonniaud (Dijon, Montpellier, France; Monastir, Tunisia)
Source:
International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells
Session:
Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells
Session type:
Oral Presentation
Number:
1418
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Burgy, G. Wettstein, P. S. Bellaye, D. Nathalie, A. Kenani, J. F. Hernandez, A. Bettaieb, P. Camus, C. Garrido, P. Bonniaud (Dijon, Montpellier, France; Monastir, Tunisia). LSC 2014 abstract - Deglycosylated bleomycin, while keeping bleomycin's antitumor activity, is devoid of its strong pulmonary toxicity. Eur Respir J 2014; 44: Suppl. 58, 1418
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
Reduction of high mobility group nucleosome binding domain-5 protein promotes the development of emphysema
Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more
Year: 2014
LSC 2014 abstract - The role of the formyl peptide receptor in the development of pulmonary fibrosis
Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells
Year: 2014
LSC 2014 abstract - Influenza infection may cause exacerbation of lung fibrosis through collagen deposition
Source: International Congress 2014 – Pulmonary fibrosis: receptors, signalling pathways and mesenchymal cells
Year: 2014
Instilled surfactant stimulates the expression of surfactant protein A, ameliorating the inhalation injury in rats
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014
An electron microscopic study of amelioration of radiation-induced lung injury by halofuginone
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
Rapid activation of pulmonary endothelial cells during high stretch ventilation
in vivo
Source: International Congress 2014 – Acute lung injury: hitting the barriers
Year: 2014
Matriptase triggers pleiotropic functional responses in normal human lung fibroblasts (NHLF): Potential relevance in pathophysiology
Source: International Congress 2014 – Lung cell biology in injury and repair
Year: 2014
Differential function of IL-17A in cigarette smoke induced lung damage
Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more
Year: 2014
Mitochondrial function and quality control is altered by low-dose cigarette smoke exposure
Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more
Year: 2014
Comparison of reducing effect on lung injury of dexamethasone and bosentan in acute lung injury: An experimental study
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014
Metalloproteases gene expression and remodeling of lung parenchyma fibers during the progression of elastase induced emphysema
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
Accelerating lung epithelial cell senescence in reduced CARM1 mice enhances elastase-induced emphysema
Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more
Year: 2014
Inhaled silver nanoparticles induce pulmonary oxidative injury and inflammation: Differential effects between rat strains
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014
Injury and repair responses of parenchymal fibroblasts in advanced chronic obstructive pulmonary disease
Source: International Congress 2014 – Mechanisms of COPD: proteases and a whole lot more
Year: 2014
Network-based approach identifies SP1 as a common node in emphysema and lung cancer
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
An experimental model of elastase and cigarette smoke- induced emphysema in mice
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
Impact of Wnt ligand secretion on cellular phenotypes in pulmonary fibrosis
Source: International Congress 2014 – New and old players in fibrotic lung disease
Year: 2014
LSC 2014 abstract - Deciphering of the mechanism of the anti-asthmatic action of the CXCL12 neutraligand, chalcone 4
Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis
Year: 2014
LSC 2014 abstract - Evaluation of paraoxonase1 activity and its relationship to the severity of lung impairment in COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept